February 14, 2025 - IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented ...

Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

CrossFi, a prominent innovator in blockchain-based financial solutions, has announced the successful completion of a rigorous ...

Have you wondered how the new law for cryptos will be in the future? Warren Buffett has stated that you simply take your dip ...

Diabetes UK reported that more than 12 million people in the UK are now living with diabetes or prediabetes. The total ...

The gambling industry is a high-stakes arena—not just for players but for money launderers exploiting its vulnerabilities.

Discover how Variable Capital Companies in Singapore provide fund managers with flexibility, tax advantages, and global ...

Maxine Waters introduces a draft bill to regulate stablecoin issuers, ensuring compliance and protecting consumers from scams.